Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Ejaculation

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    29 result(s) found for: Ejaculation. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2007-003171-39 Sponsor Protocol Number: PSD502-PE-004 Start Date*: 2007-12-07
    Sponsor Name:Plethora Solutions Ltd
    Full Title: A phase III, multi-centre, randomized, double-blind, placebo-controlled study, with open-label follow on, to evaluate the efficacy, safety and tolerability of PDS502 in subjects with Premature Ejac...
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed) HU (Completed) CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-011855-40 Sponsor Protocol Number: OTB109059 Start Date*: 2009-11-26
    Sponsor Name:GlaxoSmithKline Research and Development Ltd
    Full Title: A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Doub...
    Medical condition: Premature ejaculation.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation LLT
    Population Age: Adults Gender: Male
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2009-011309-18 Sponsor Protocol Number: R096769PRE4001 Start Date*: 2009-12-02
    Sponsor Name:Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium
    Full Title: A Prospective, Observational Study of Men With Premature Ejaculation Who Are Treated With PRILIGY™ or Alternate Care
    Medical condition: premature ejaculation
    Disease: Version SOC Term Classification Code Term Level
    12.0 10036596 Premature ejaculation PT
    Population Age: Adults Gender: Male
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2013-001650-94 Sponsor Protocol Number: 191622-133 Start Date*: 2013-08-06
    Sponsor Name:Allergan Limited
    Full Title: An Exploratory Study of the Safety and Efficacy of BOTOX® for the Treatment of Premature Ejaculation
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    14.1 10037175 - Psychiatric disorders 10036596 Premature ejaculation PT
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-000244-24 Sponsor Protocol Number: A3871027 Start Date*: 2004-08-18
    Sponsor Name:Pfizer AB
    Full Title: A Phase 2b, multi-center, double-blind, placebo-controlled, parallel group dose response study to assess the efficacy and safety of oral UK-390,957 in men with premature ejaculation.
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    7.0 10036596 LLT
    Population Age: Adults Gender: Male
    Trial protocol: SE (Completed) HU (Completed) IT (Completed) ES (Completed) CZ (Completed)
    Trial results: View results
    EudraCT Number: 2008-003650-15 Sponsor Protocol Number: PSD502-PE-005 Start Date*: 2008-12-29
    Sponsor Name:Plethora Solutions Ltd
    Full Title: A Phase II, multi-centre, double-blind, randomised, placebo-controlled, 4-way cross-over, dose-range finding study to evaluate efficacy and safety and tolerability of PSD502 in subjects with premat...
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005319-16 Sponsor Protocol Number: SPE111155 Start Date*: 2008-11-14
    Sponsor Name:GLAXO SMITHKLINE
    Full Title: ``A double blind, parallel group, placebo controlled study to evaluate the effect of a single oral dose of GSK958108 on ejaculatory latency time (ELT) in male patients suffering from premature ejac...
    Medical condition: Premature ejaculation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation LLT
    Population Age: Adults Gender: Male
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-011411-21 Sponsor Protocol Number: BVF-324-302 Start Date*: 2009-07-17
    Sponsor Name:Biovail Laboratories International SRL, c/o Biovail Technologies Ltd
    Full Title: A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Pre...
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation LLT
    Population Age: Adults Gender: Male
    Trial protocol: HU (Prematurely Ended) BG (Prematurely Ended) CZ (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-011410-18 Sponsor Protocol Number: BVF-324-301 Start Date*: 2009-07-29
    Sponsor Name:Biovail Laboratories International SRL, c/o Biovail Technologies Ltd
    Full Title: A Randomized, Double-blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Two Doses of Tramadol Hydrochloride Orally Disintegrating Tablets in Male Subjects with Pre...
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036596 Premature ejaculation LLT
    Population Age: Adults Gender: Male
    Trial protocol: BE (Completed) DE (Prematurely Ended) FR (Completed) SE (Prematurely Ended) ES (Completed) GB (Prematurely Ended) NL (Prematurely Ended) AT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2004-003737-13 Sponsor Protocol Number: A3871028 Start Date*: 2004-11-25
    Sponsor Name:Pfizer Corporation Austria Ges.m.b.H., Clinical Research
    Full Title: A Phase 2 multi-center, open label, long-term extension trial to assess the safety and sustained efficacy of oral UK-390,957 administered as required in adult men with premature ejaculation.
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    7.0 10036596 LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: AT (Completed) SE (Completed) CZ (Completed) GB (Prematurely Ended) DE (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2004-004150-51 Sponsor Protocol Number: A3871029 Start Date*: 2004-12-10
    Sponsor Name:Pfizer Limited
    Full Title: A Phase 2 multi centre, double blind, placebo controlled flexible dose study to assess the efficacy and safety of oral UK-390,957 in men with premature ejaculation.
    Medical condition: Premature Ejaculation
    Disease: Version SOC Term Classification Code Term Level
    7.0 10036596 LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-013616-12 Sponsor Protocol Number: R096769PRE3008 Start Date*: 2010-04-12
    Sponsor Name:Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium
    Full Title: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of the Efficacy and Safety of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dy...
    Medical condition: Premature ejaculation
    Disease: Version SOC Term Classification Code Term Level
    12.1 10036596 Premature ejaculation LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: BE (Completed) FR (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-002700-16 Sponsor Protocol Number: R096769-PRE-3001 Start Date*: 2004-12-14
    Sponsor Name:Janssen-Cilag International N.V.
    Full Title: A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Subjects With Premature Ejaculation
    Medical condition: Premature Ejaculation (PE)
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: CZ (Completed) FI (Completed) HU (Completed) GB (Completed) SE (Completed) DE (Completed) AT (Completed) ES (Completed) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-004065-42 Sponsor Protocol Number: VR776/008 Start Date*: 2006-01-23
    Sponsor Name:Vectura Group plc
    Full Title: Phase II, double blind, intermittent dose, placebo controlled, randomised, two period crossover study to investigate the effect of inhaled doses of VR776 administered via Aspirair inhaler on IVELT ...
    Medical condition: Premature ejaculation
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2004-004761-15 Sponsor Protocol Number: 1 Start Date*: 2005-10-12
    Sponsor Name:City University
    Full Title: Rapid Ejaculation: An exploration of the pharmacological and behavioural therapies in men living in East London and a preliminary trial of these treatment modalities
    Medical condition: Premature ejaculation
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-011499-31 Sponsor Protocol Number: SIA-001-2008 Start Date*: 2009-08-05
    Sponsor Name:SOCIETA` ITALIANA DI ANDROLOGIA
    Full Title: STUDIO PROSPETTICO RANDOMIZZATO DI VALUTAZIONE DEI DIFFERENTI APPROCCI TERAPEUTICI AL DISAGIO SESSUALE AD ESPRESSIONE SULLA SFERA ERETTILE
    Medical condition: DISAGIO SESSUALE: “Condizione e/o senso di inadeguatezza, non a carattere transitorio, tale da provocare una compromissione della salute sessuale (OMS working definition). L’inadeguatezza puo' orig...
    Disease: Version SOC Term Classification Code Term Level
    9.1 10013305 Erection and ejaculation conditions and disorders HLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-010549-30 Sponsor Protocol Number: 44/09 Start Date*: 2009-12-16
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: PRAMIPEXOLE IN THE MALE LIBIDO FAILURE : A PHASE II, off-label, pilot study
    Medical condition: male libido failure
    Disease: Version SOC Term Classification Code Term Level
    9.1 10024419 PT
    Population Age: Adults Gender: Male
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2013-001511-70 Sponsor Protocol Number: 44313 Start Date*: 2015-08-05
    Sponsor Name:Maastricht University Medical Center
    Full Title: Efficacy, safety and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutations related small fiber neuropathy: a randomized, double-blind, placebo controlled, crossover trial
    Medical condition: SCN9A mutation related small fiber neuropathy
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-002897-27 Sponsor Protocol Number: 18E-Prg06 Start Date*: 2018-12-21
    Sponsor Name:IBSA, Institut Biochimique, S.A.
    Full Title: A proof of concept, randomized, controlled clinical trial to assess the efficacy of subcutaneous progesterone (Prolutex) versus vaginal proges-terone (Progeffik) for endometrial preparation in wome...
    Medical condition: Infertility. Assisted Reproductive Tecniques.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10073184 Embryo transfer LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: View results
    EudraCT Number: 2014-004784-20 Sponsor Protocol Number: BER-PRO-2014-01 Start Date*: 2015-01-22
    Sponsor Name:Instituto Bernabeu
    Full Title: Subcutaneous progesterone ( Prolutex ) versus vaginal progesterone capsules (Progeffik) for endometrial preparation in fresh donated oocyte recipients: A prospective, randomized, single-blind, pi...
    Medical condition: Infertility. Assisted Reproductive Techniques. Fresh donated oocyte recipients
    Disease: Version SOC Term Classification Code Term Level
    17.1 10038604 - Reproductive system and breast disorders 10021928 Infertility female PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 07:44:40 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA